Drug intelligence / Profile preview

modified Sijunzi decoction granule

Development stage
Unknown
Lead developer
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration
Oral
01

Overview

Modified Sijunzi decoction granule is a Traditional Chinese Medicine (TCM) botanical formulation developed by The First Affiliated Hospital of Guangzhou University of Chinese Medicine. It is specifically designed for the treatment of ulcerative colitis in the remission phase, targeting the "dampness stagnancy due to spleen deficiency" syndrome. The formula is a modification of the classic Sijunzi Decoction, which traditionally contains *Panax ginseng*, *Atractylodes macrocephala*, *Poria cocos*, and *Glycyrrhiza uralensis*. The modification involves adding specific herbs to address the dampness and chronic inflammation associated with colitis. In clinical studies, it is compared against mesalazine to evaluate its efficacy in maintaining remission and improving TCM-specific symptoms.

Other names
Modified Chinese Medicine GranuleModified Sijunzi DecoctionJiajian Sijunzi Tang
02

Targets

IL-6 (Interleukin 6)

Beyond the preview

Go deeper on modified Sijunzi decoction granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified Sijunzi decoction granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call